Stocks Health care CPHI
NYSE · Health careChina Pharma Holdings, Inc. (CPHI)
China Pharma Holdings, Inc. brought in $3.9M of revenue over the twelve months to June 30, 2026, down 11.0% from a year earlier. It posted a net loss of $4.5M. Operating cash flow minus capital spending left $88.9K of free cash flow in fiscal 2025. At June 30, 2026 it held $304.9K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Key facts about China Pharma Holdings, Inc.
- Net worth
- China Pharma Holdings, Inc. has a market value (market cap) of $23.7M at the latest share price, and shareholders' equity of $36.2M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $4.1M (-8.5% year on year), with a net loss of $3.2M. Over the 12 months to June 30, 2026: revenue $3.9M, net loss $4.5M.
- Cash flow
- In fiscal 2025 operations brought in $148.3K of cash; after $59.3K of capital spending, free cash flow was $88.9K.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 14, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- China Pharma Holdings, Inc.'s next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What China Pharma Holdings, Inc. does
China Pharma Holdings, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker CPHI.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $4.1M | -$3.2M | -$0.74 | $88.9K |
| 2024 | $4.5M | -$4.7M | -$2.71 | -$444.5K |
| 2023 | $7M | -$3.1M | -$9.13 | -$711.2K |
| 2022 | $8.1M | -$4M | -$37.94 | -$811.5K |
| 2021 | $9.6M | -$3.4M | -$36.94 | -$687.9K |
| 2020 | $10.9M | -$2.9M | -$36.94 | -$909.6K |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where CPHI ranks in Health care
Latest SEC filings
What China Pharma Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 7.5% to $948.3K versus the same quarter last year; diluted EPS -$0.04 versus -$0.16.
- July 22, 2026
- May 15, 2026Quarterly report 10-Q · period to March 31, 2026Revenue fell 13% to $983.5K versus the same quarter last year; diluted EPS -$0.04 versus -$0.24.
- April 1, 2026Annual report 10-K · period to December 31, 2025Revenue fell 8.5% to $4.1M versus the prior year; diluted EPS -$0.74 versus -$2.71.
- April 1, 2026Late annual report notice NT 10-K
- March 3, 2026
- February 10, 2026
- January 6, 2026
- December 23, 2025
- December 10, 2025
What is CPHI worth? A DCF from its reported cash flow
Insider trades
What the people running China Pharma Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Questions about CPHI
What does China Pharma Holdings, Inc. do?
China Pharma Holdings, Inc. is a company in the Health care sector, listed on NYSE as CPHI. Its shares trade on NYSE under the ticker CPHI.
What is China Pharma Holdings, Inc.'s net worth?
China Pharma Holdings, Inc. has a market value (market cap) of $23.7M at the latest share price, and shareholders' equity of $36.2M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is China Pharma Holdings, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $4.5M on revenue of $3.9M.
How much revenue does China Pharma Holdings, Inc. make?
Over the twelve months to June 30, 2026 China Pharma Holdings, Inc. reported revenue of $3.9M. That is 11.0% less than a year earlier.
When did China Pharma Holdings, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026.
When is China Pharma Holdings, Inc.'s next earnings report?
China Pharma Holdings, Inc.'s next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare CPHI with
Follow CPHI
Get an email when China Pharma Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values China Pharma Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.